Today: 29 January 2026
Subscribe
Browse Category

NASDAQ:CRNX News 7 January 2026

Crinetics (CRNX) shares jump as $350 million stock sale clears and early PALSONIFY revenue hits

Crinetics (CRNX) shares jump as $350 million stock sale clears and early PALSONIFY revenue hits

New York, Jan 7, 2026, 11:04 EST — Regular session Shares of Crinetics Pharmaceuticals rose about 16% to $53.40 on Wednesday, after the biotech priced a $350 million stock offering and detailed early U.S. launch metrics for its newly approved acromegaly drug. Crinetics said it generated preliminary, unaudited net product revenue of more than $5 million from PALSONIFY in the…
7 January 2026
·····

Stock Market Today

  • Foresight Group Holdings conducts share buyback purchasing 39,726 shares
    January 29, 2026, 2:16 AM EST. Foresight Group Holdings Limited announced a purchase of 39,726 ordinary shares on January 28, 2026, as part of its ongoing share buyback programme initiated in April 2025. The shares were acquired at prices ranging from 427 to 433 GBp, with a volume-weighted average price of 431.6 GBp. Post-transaction, the Group holds a total of 1,508,272 shares in treasury, which carry no voting rights. Overall, 3,159,956 ordinary shares have been repurchased under the programme. The buyback was executed through Berenberg on the London Stock Exchange. The total Ordinary Shares in issue stand at 116,347,803, with 114,839,531 carrying voting rights. This latest activity reflects Foresight's strategy to optimize its capital structure.
Go toTop